Macuject logo — Combining AI insights with human expertise to end preventabl...

Macuject

Combining AI insights with human expertise to end preventable blindness

Founded 2017 Australia Melbourne, Australia 10 employees Seed AI, Health Care

General Information

Company Name Macuject
Founded Year 2017
Location Australia Melbourne, Australia +1
Employees 10
Industries AI, Health Care
Funding Stage Seed
Social

Get notified when Macuject moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Macuject

Macuject is a clinician-driven digital health company founded in 2017 and headquartered in Australia. The company's vision, as reflected in their slogan "Combining AI insights with human expertise to end preventable blindness," is to tackle preventable blindness, starting with age-related macular degeneration (AMD) and subsequently addressing diabetic retinopathy, cataract, and glaucoma. Macuject's innovative clinical decision support software is designed to cater to both wet and dry forms of AMD, facilitating accurate diagnoses, optimized treatment plans, and enhanced disease progression monitoring. By leveraging cutting-edge artificial intelligence and seamlessly integrating with existing medical infrastructure, their SaaS solutions enable early intervention and personalized care, resulting in improved patient outcomes and reduced social and economic burdens related to these conditions. The founder-CEO of Macuject is Dr. Devinder Chauhan, a prominent Melbourne retinal specialist known for 8% of AMD treatments in his state. Dr. Chauhan has assembled a diverse and talented team with expertise in commercial, technical, and clinical development to drive the company's innovative products forward, ensuring their clinical relevance and market adoption. As of now, there is no public information available regarding the last investment and the associated investors for Macuject. With its focus on leveraging AI in the healthcare sector, Macuject appears to be positioned for compelling growth and impact in addressing preventable blindness.

No funding data available for Macuject yet.

Get notified when Macuject raises funding

Macuject Alternatives & Competitors

Macuject vs

Developing HMR59, an intravitreal gene therapy, to preserve vision in eyes with dry age-related macu...

Series Unknown
1 employees
Biotechnology
Macuject vs

Treatment for drug & alcohol addiction, eating disorders, and mental health conditions. In-network w...

39 employees
Health Care, Health and Wellness
Macuject vs

Affair Recovery specializes in helping people heal after infidelity. After recovering from his own a...

15 employees
Health and Wellness

FAQ About Macuject

Combining AI insights with human expertise to end preventable blindness
Macuject was founded in 2017.
Macuject is headquartered in Melbourne, Australia.
Macuject operates in the following industries: AI, Health Care.
Macuject has approximately 10 employees.
Top alternatives and competitors to Macuject include Hemera Biosciences LLC, Fairwinds Treatment Center, Affair Recovery, Exegenesis Bio, Celltechgen Laboratory. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Macuject and Hemera Biosciences LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Macuject and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy